ALEXION PHARMACEUTICALS INC's ticker is and the CUSIP is 015351959. A total of 5 filers reported holding ALEXION PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $10,000 | -68.8% | 15,400 | -92.3% | 0.00% | – |
| Q4 2020 | $32,000 | -97.0% | 199,400 | +8.4% | 0.00% | -100.0% |
| Q3 2020 | $1,061,000 | -21.9% | 184,000 | -29.8% | 0.01% | -36.4% |
| Q2 2020 | $1,359,000 | +123.5% | 262,100 | +75.3% | 0.01% | +83.3% |
| Q1 2020 | $608,000 | +781.2% | 149,500 | +896.7% | 0.01% | +500.0% |
| Q4 2019 | $69,000 | -87.5% | 15,000 | -69.7% | 0.00% | -80.0% |
| Q4 2017 | $554,000 | +128.9% | 49,500 | 0.0% | 0.01% | +150.0% |
| Q3 2017 | $242,000 | -73.2% | 49,500 | 0.0% | 0.00% | -75.0% |
| Q2 2017 | $902,000 | -11.7% | 49,500 | 0.0% | 0.01% | -11.1% |
| Q1 2017 | $1,022,000 | -17.7% | 49,500 | 0.0% | 0.01% | -10.0% |
| Q4 2016 | $1,242,000 | +7.7% | 49,500 | 0.0% | 0.01% | -16.7% |
| Q3 2016 | $1,153,000 | -22.9% | 49,500 | 0.0% | 0.01% | +9.1% |
| Q2 2016 | $1,495,000 | +160.0% | 49,500 | -1.0% | 0.01% | +266.7% |
| Q3 2015 | $575,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delek Group, Ltd. | 50,000 | $6,549,000 | 0.25% |
| GROUP ONE TRADING, L.P. | 40,700 | $5,331,000 | 0.05% |
| SIMPLEX TRADING, LLC | 1,289 | $16,883,000 | 0.05% |
| COMMERZBANK AKTIENGESELLSCHAFT /FI | 14,800 | $1,939,000 | 0.01% |
| JPMORGAN CHASE & CO | 231,500 | $29,194,000 | 0.01% |
| IMC-Chicago, LLC | 10,800 | $1,415,000 | 0.01% |
| Allianz Asset Management GmbH | 19,400 | $2,541,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Itau Unibanco Holding S.A. | 51 | $0 | 0.00% |